KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Current Deferred Revenue: 2017-2025

Historic Current Deferred Revenue for Elanco Animal Health (ELAN) over the last 8 years, with Sep 2025 value amounting to $376.0 million.

  • Elanco Animal Health's Current Deferred Revenue rose 12.91% to $376.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $376.0 million, marking a year-over-year increase of 12.91%. This contributed to the annual value of $332.0 million for FY2024, which is 9.54% down from last year.
  • As of Q3 2025, Elanco Animal Health's Current Deferred Revenue stood at $376.0 million, which was up 2.45% from $367.0 million recorded in Q2 2025.
  • Elanco Animal Health's Current Deferred Revenue's 5-year high stood at $376.0 million during Q3 2025, with a 5-year trough of $284.0 million in Q2 2022.
  • Over the past 3 years, Elanco Animal Health's median Current Deferred Revenue value was $333.0 million (recorded in 2024), while the average stood at $344.1 million.
  • As far as peak fluctuations go, Elanco Animal Health's Current Deferred Revenue soared by 108.18% in 2021, and later decreased by 10.88% in 2022.
  • Over the past 5 years, Elanco Animal Health's Current Deferred Revenue (Quarterly) stood at $319.0 million in 2021, then increased by 1.57% to $324.0 million in 2022, then increased by 13.27% to $367.0 million in 2023, then dropped by 9.54% to $332.0 million in 2024, then increased by 12.91% to $376.0 million in 2025.
  • Its Current Deferred Revenue was $376.0 million in Q3 2025, compared to $367.0 million in Q2 2025 and $319.0 million in Q1 2025.